Molecular interaction fingerprint approaches for GPCR drug discovery

被引:37
|
作者
Vass, Marton [1 ]
Kooistra, Albert J. [1 ,2 ]
Ritschel, Tina [1 ,2 ]
Leurs, Rob [1 ]
de Esch, Iwan J. P. [1 ]
de Graaf, Chris [1 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Div Med Chem, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, CMBI, Geert Grootepl Zuid 26-28, NL-6525 GA Nijmegen, Netherlands
关键词
LIGAND INTERACTION PATTERNS; FRAGMENT-LIKE LIGANDS; BINDING-SITE; HISTAMINE H-1; SC-PDB; PROTEIN; SIMILARITY; CONSENSUS; DOCKING; TARGET;
D O I
10.1016/j.coph.2016.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Protein-ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein-ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein-ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [21] Recent progress in assays for GPCR drug discovery
    Guo, Shimeng
    Zhao, Tingting
    Yun, Ying
    Xie, Xin
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2022, 323 (02): : C583 - C594
  • [22] The Role of Binding Kinetics in GPCR Drug Discovery
    Swinney, David C.
    Haubrich, Brad A.
    Van Liefde, Isabelle
    Vauquelin, Georges
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (24) : 2504 - 2522
  • [23] Structure, function and drug discovery of GPCR signaling
    Lin Cheng
    Fan Xia
    Ziyan Li
    Chenglong Shen
    Zhiqian Yang
    Hanlin Hou
    Suyue Sun
    Yuying Feng
    Xihao Yong
    Xiaowen Tian
    Hongxi Qin
    Wei Yan
    Zhenhua Shao
    Molecular Biomedicine, 4
  • [24] Structure, function and drug discovery of GPCR signaling
    Cheng, Lin
    Xia, Fan
    Li, Ziyan
    Shen, Chenglong
    Yang, Zhiqian
    Hou, Hanlin
    Sun, Suyue
    Feng, Yuying
    Yong, Xihao
    Tian, Xiaowen
    Qin, Hongxi
    Yan, Wei
    Shao, Zhenhua
    MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [25] GPCR panel establishment and application in drug discovery
    Wang, Xiaoyan
    Sui, Ning
    Hu, Dandan
    Zhang, Ziwei
    Bing, Tiejun
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Intercellular Lipid Mediators and GPCR Drug Discovery
    Im, Dong-Soon
    BIOMOLECULES & THERAPEUTICS, 2013, 21 (06) : 411 - 422
  • [27] GPCR insights brighten drug discovery outlook
    Doyle, K., 1600, Mary Ann Liebert Inc. (34):
  • [28] Emerging approaches in molecular profiling affecting oncology drug discovery
    Friend, S. H.
    Molecular Approaches to Controlling Cancer, 2005, 70 : 445 - 448
  • [29] APPROACHES TO DRUG DISCOVERY
    BURGER, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1964, 270 (21): : 1098 - &
  • [30] Innovation in bioanalytical strategies and in vitro drug-drug interaction study approaches in drug discovery
    Kumar, Saraswathisreeram Pranush
    Sherpa, Deeki Doma
    Sahu, Amit Kumar
    Jadav, Tarang
    Tekade, Rakesh Kumar
    Sengupta, Pinaki
    BIOANALYSIS, 2021, 13 (06) : 513 - 532